Featured

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

North America Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Artificial intelligence (AI) #Automation #Benchling #Drug discovery #Webinar

Europe Session – From reaction to result: Connecting chemistry and biology for smarter drug discovery

A molecule passes through many hands in drug discovery. Medicinal chemists design and synthesise it, analytical scientists characterise it, and biology teams evaluate its activity. Yet the scientific knowledge generated along the way often remains fragmented across disconnected systems, making it difficult to connect what was made, how it was… Read More

Webinar date:
Supported by Benchling
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Immunoassays #Webinar

Measuring what matters: Applying ultrasensitive immunoassays for clinical biomarkers

When biomarkers are present at very low concentrations, conventional immunoassays may not provide the sensitivity needed to generate reliable, meaningful data. This can limit the ability to assess target engagement, monitor pharmacodynamic responses and track biomarker changes during treatment. Ultrasensitive immunoassays offer new opportunities to address these challenges. In this… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

#Crown Bioscience #Drug discovery #PDX models #Webinar

Beyond the model: Exploring warm PDX benefits and onsite expertise

Patient-derived xenograft (PDX) models are a valuable tool in oncology research, helping researchers evaluate therapeutic efficacy in preclinical settings using models that retain key characteristics of human tumours. In this webinar, Crown Bioscience will highlight the capabilities of its PDX model portfolio, with a particular focus on the benefits of… Read More

Webinar date:
Supported by Crown Bioscience
#Featured Webinars #Webinars

#Biomarkers #Drug discovery #Evotec #Webinar

From PK/PD and Biomarkers to decision-making: How modeling shapes clinical strategy

Clinical trials continue to experience high attrition rates, with lack of efficacy being one of the leading causes of failure. However, in many cases, these failures do not reflect a lack of drug efficacy, but rather limitations in translational biomarker strategies and selection of disease-relevant pharmacodynamic (PD) biomarkers, suboptimal dose… Read More

Webinar date:
Supported by Evotec
#Featured Webinars #Webinars

Cell and gene therapy
#Cell and gene therapy #Cell therapy #Drug development #Drug discovery #Gene therapy

Advances and challenges in cell and gene therapies

Hosted by Drug Discovery World and supported by Bio-Techne, this webinar explores the advances and challenges taking place within the cell and gene therapy field. Hear from Hans Schambye CEO at BOOST Pharma, Lucas Arruda, CSO at CuraCell, and Brandon Cieniewicz, Director, Research & Development at CERo Therapeutics. Throughout the… Read More

Webinar date:
Sponsored by Bio-Techne
#Featured Webinars

Webinars

Antibodies
#Antibodies #Antibody drug conjugate (ADC) #Biologics #Therapeutic Antibodies

What are the drivers and challenges in therapeutic antibody discovery?

In this free webinar, hosted by DDW and sponsored by Bio-Rad, you will learn about the innovation taking place within the therapeutic antibody sector and what the current opportunities and challenges are for drug developers in the industry. You will hear from Aron Knickerbocker, CEO of Aulos Bioscience, and Martin… Read More

Webinar date:
Sponsored by Bio-Rad
#Webinars

#Artificial intelligence (AI) #Data automation #Drug discovery #Laboratory data

Enable AI-ready data with data automation

The adoption of AI/ML in life science R&D is hindered by the lack of high-quality, well-structured data and metadata, a challenge exacerbated by a proliferation of proprietary instrument data formats, siloed lab software applications, and the absence of wet lab-friendly data automation platforms. While some workflow-specific solutions exist, they are… Read More

Webinar date:
Supported by Benchling
#Webinars

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA

Using ENFINIA™ cell-free synthesised DNA for rapid protein expression and screening in the myTXTL® cell-free system

Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven approaches, biomanufacturing, and more. However, reliance on plasmid DNA templates for expression requires time-consuming cloning steps, limiting speed and efficiency. In this webinar, supported by Elegen,… Read More

Webinar date:
Supported by Elegen
#Webinars

#Genetics / genomics #Mouse models #Preclinical development #Preclinical investigations

Safeguarding Genetic Integrity in Preclinical Rodent Models

Join geneticist Bart Smits, PhD in this exclusive webinar as he outlines key considerations for designing and maintaining a robust mouse colony to support your preclinical research needs. Secure your spot to: Understand the impact of background strain and substrain on mutation expression. Explore effective… Read More

Webinar date:
Brought to you by Taconic Biosciences
#Webinars

The benefits of generative AI in drug discovery

It can take years, and cost billions, to get new drugs approved for clinical use, but technological advances are transforming drug discovery and development. The growing shift towards artificial intelligence (AI), including generative and predictive AI, can reduce the amount of time and money it takes to develop new drugs. Read More

Webinar date:
Supported by Amazon Web Services and NVIDIA
#Webinars

Organoid
#High throughput screening #iPSC #Live cell analysis #Organoids #Phenotyping #Stem cells

From iPSCs to Organoids: Streamlined Hepatic Differentiation Techniques

In this webinar, we describe the process of differentiating human iPSCs into hepatocytes using three distinct media types, each supplemented with specific growth factors and cytokines at key stages of differentiation. This method provides a relatively straightforward approach to producing mature hepatic cells, enabling the generation of human hepatic organoids… Read More

Webinar date:
Supported by Sartorius
#Webinars

#3D imaging #Artificial intelligence (AI) #Cell Science #In vitro #Organoids

Advancing drug discovery by combining complex in vitro models with AI-powered 3D/4D image analysis

The FDA’s approval of organoids in preclinical research has catalysed a major shift toward complex in vitro models (CIVM) for drug testing and disease research. The implementation of more biologically relevant phenotypic model formats, however, requires an evolution of imaging and analysis techniques. Traditional 2D high-content analysis (HCA) approaches fall… Read More

Webinar date:
Supported by Zeiss
#Webinars

#Advanced Therapies #Cell and gene therapy #Cell therapy #Gene editing #Gene therapy

Cell & Gene Therapy Showcase

In this free online event leading industry figures outline areas of opportunity in CGT drug discovery and development sector as well as highlighting challenges facing the industry and how they can be overcome. It features presentations from experts in the field of cell and gene therapy drug development as well… Read More

Webinar date:
Co-sponsored by Benchling, Sartorius, Applied StemCell, and Elegen Bio
#Webinars

#ADME / Tox #Human disease models #In vitro #iPSC #Toxicology

Principles, pitfalls, and progress in modelling human liver toxicity and pharmacology in vitro

In this webinar hosted by DDW and supported by bit.bio, Dr Stephen Ferguson, Investigator, Mechanistic Toxicology, Division of Translational Toxicology (DTT), National Institute of Environmental Health Sciences, explores the complexities of in vitro modelling for human liver toxicity and pharmacology. He discusses the development… Read More

Webinar date:
Supported by bit.bio
#Webinars

CAR-T cells attacking a cancer cell
#CAR-T #Cell therapy #High throughput screening #Live cell analysis #Oncology

Characterisation of CAR-T cells: Integrating live-cell analysis and high-throughput cytometry

The development of gene-modified cell therapies, particularly CAR-T cells, has transformed cancer treatment by offering personalised and potentially curative options. This webinar, hosted by DDW and supported by Sartorius, explores the integration of live-cell analysis and high-throughput screening (HTS) by cytometry to enhance the characterisation of CAR-T cells. Key topics… Read More

Webinar date:
Supported by Sartorius
#Webinars

#antibiotic #Antibiotics #Cryo-EM #cryo-microscopy

Structural characterisation of a novel class of antibacterials that target MsbA in multidrug-resistant Acinetobacter baumannii

In this webinar, hosted by DDW and supported by Thermo Fisher Scientific, you will learn about the current advancements taking place in antibiotic drug discovery. This webinar highlights how cryo-electron microscopy (cryo-EM) can be used to target the lipopolysaccharide transporter MsbA in multidrug-resistant Acinetobacter baumannii. This pathogen is a major… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars

Cell and gene therapy concept
#Cell and gene therapy #Cell therapy #Gene therapy #RNA

What are the challenges and advancements driving CGT drug development?

In this webinar you will hear from Erik Wiklund, CEO of Circio, Ali Pashazadeh, CEO of Treehill Partners, and Gerard Caelles, CBO at Splice Bio. Erik Wiklund will discuss how circular RNA is crucial to the development of next-generation cell and gene therapy products. Ali Pashazadeh will explore current barriers… Read More

Webinar date:
Sponsored by Benchling and Applied StemCell
#Webinars

#Amyotrophic lateral sclerosis (ALS) #CNS #Drug discovery #Neuroscience

The latest advancements driving neuroscience drug discovery research

In this webinar, hosted by DDW and sponsored by ApconiX, you will hear from Dr Isaac Klein, Chief Scientific Officer at Dewpoint Therapeutics, Dr Sam Clark, CEO of Terran Biosciences, and Professor Ruth Roberts, Co-founder and Director of Safety Science at ApconiX. Dr Klein shares how Dewpoint applies insights into… Read More

Webinar date:
Supported by Apconix
#Webinars

#Drug development #Drug discovery #Drug technology #Neuroscience

Neuroscience Showcase

In this free online event, hosted by DDW and sponsored by ApconiX and AxoSim, leading industry figures will outline the areas of opportunity and challenges in the neuroscience drug discovery & development sector. The showcase will include a panel discussion looking at the use of new drug discovery and development… Read More

Webinar date:
Sponsored by ApconiX and AxoSim
#Webinars

Biosafety cabinet
#Biosafety testing #Lab technology #Laboratory

Customizing Biosafety Cabinets: A Holistic Approach

Watch this on-demand webinar to learn more about: Situations that may require a bespoke biosafety cabinet (BSC) instead of a standard one The process to collaborate with a manufacturer to build a BSC around your needs Planning for the unique certification and service requirements of a bespoke design… Read More

Webinar date:
Brought to you by Nuaire
#Webinars

#AAV #Cryo-EM #cryo-microscopy #Drug discovery #Gene therapy

Quantitative analysis of full and empty particles in adeno-associated virus vectors for gene therapy

In this event, Professor Susumu Uchiyama, Department of Biotechnology, Graduate School of Engineering, Osaka University, presents his work around adeno-associated virus (AAV) characterisation using cryo-electron microscopy. In recent years, AAV vectors have been launched and are considered one of the main platforms for gene therapy, with more than 250 clinical… Read More

Webinar date:
Supported by Thermo Fisher Scientific
#Webinars